ICLR News and Press, ICON plc From 02/03/23

Summary Waters Corporation has been a source of relative stability over the past several months, with the company performing slightly better than the broader market. This comes as sales rise but also while profits and cash flows come under some pressure. If shares were cheaper, the ...

ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the fourth quarter 2022 after the market closes on Wednesday, February 22, 2023. The company will hold a conference c...

Clinical research organization ICON ( NASDAQ: ICLR ) said its FY23 revenue is expected to be in the range of $7.94M to $8.34M, vs. a consensus of $8.17B. FY23 EPS is expected to be in the range of $12.40 – $13.05, vs. a consensus of $12.29. The full-y...

Highlights Full Year 2023 Revenue guidance in the range of $7,940 - $8,340 million, representing growth of 3.3% – 6.8% over Full Year 2022 Revenue guidance. Full Year 2023 adjusted earnings per share 1 guidance in the range of $12.40 - $13.05, representing growth of 6.4% &#...

Summary BAMCO’s 13F portfolio value decreased from $31.14B to $30.95B this quarter. Ron Baron decreased Rivian Automotive and Alphabet during the quarter. Their top five positions are at ~31% of the overall portfolio. This article is part of a series that provides an on...

ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 5:15pm PST/ 8.15pm EST. Any ch...

ICON finishes the second half of 2022 with an impressive line-up of awards that commend its healthcare intelligence work and status as an employer of choice, as independently judged by industry leaders and peers worldwide. ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelli...

ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022. The presentation will be webc...

Summary Mettler-Toledo has done really well for itself lately, with sales, profits, and cash flows coming in strong. Long term, the company should fare well for itself, but this does not make it an ideal prospect to consider. Investors should be cautious given how shares are p...

Summary ICON Plc has faced heavy selling pressure in FY22 amid the broad selloff in equities. There's conflicting information whether its latest rally is extendable beyond previous highs. Q3 numbers weren't supportive with cash earnings tightening and ROIC a negative spread be...